World

A German vaccine can save from COVID-19 from November

[ad_1] PHOTO: Pixabay The BNT162b2 coronavirus vaccine, developed by giant Pfizer and biotech company BioNTech, could receive emergency approval from November, SPIEGEL reported. It is one of 10 in the final third phase of testing and its effectiveness can be confirmed by the end of October, Dariknews reported. The scientists …

Read More »